HER2 quantitative continuous scoring for accurate patient selection in HER2 negative trastuzumab deruxtecan treated breast cancer

Abstract Many targeted cancer therapies rely on biomarkers assessed by scoring of immunohistochemically (IHC)-stained tissue, which is subjective, semiquantitative, and does not account for expression heterogeneity. We describe an image analysis-based method for quantitative continuous scoring (QCS)...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Ansh Kapil, Andreas Spitzmüller, Nicolas Brieu, Susanne Haneder, Anatoliy Shumilov, Armin Meier, Fabiola Cecchi, Alice Barkell, Nathalie Harder, Katrin Mittermaier, Ana Hidalgo-Sastre, Regina Alleze, Markus Schick, Günter Schmidt, Hadassah Sade, Zenta Tsuchihashi, Fumitaka Suto, Mark Gustavson, J. Carl Barrett, Danielle Carroll
Format:	Artigo
Język:	Inglês
Wydane:	Nature Portfolio 2024-05-01
Seria:	Scientific Reports
Dostęp online:	https://doi.org/10.1038/s41598-024-61957-9
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!